Ontology highlight
ABSTRACT: Purpose
Heat shock proteins (HSP-27) are reported to be involved in the pathophysiology of diabetes complications. The purpose of the current study is to assess the effects of eicosapentaenoic acid (EPA) supplementation on serum HSP-27, glycemic status and anthropometric indices in type 2 diabetes mellitus (T2DM) patients.Methods
Thirty-six patients with T2DM were randomly allocated to obtain 2 g per day EPA (n = 18) or placebo (n = 18) for 8 weeks in a randomized, double-blind, placebo-controlled clinical trial. Fasting serum levels of HSP 27, fasting blood sugar, hemoglobin A1C, as well as anthropometric indices were measured.Results
EPA supplementation reduces the serum level of HSP 27 in the EPA group compared with the placebo (P < 0.03). Although waist circumference (WC) decreased significantly in the EPA group at the end of the trial (P < 0.02), there was no significant difference in weight, WC, body mass index (BMI), and glycemic markers in both groups after intervention (P > 0.05).Conclusions
We found that EPA supplementation reduces HSP 27 serum level in T2DM patients. However, future large-scale trials are needed.
SUBMITTER: Ghaedi E
PROVIDER: S-EPMC10225421 | biostudies-literature | 2023 Jun
REPOSITORIES: biostudies-literature
Ghaedi Ehsan E Sharifdini Javad Galyan JG Javanbakht Mohammad Hassan MH Mohammadi Hamed H Golzari Mohammad Hassan MH Zarei Mahnaz M Hadi Amir A Djalali Mahmoud M
Journal of diabetes and metabolic disorders 20221222 1
<h4>Purpose</h4>Heat shock proteins (HSP-27) are reported to be involved in the pathophysiology of diabetes complications. The purpose of the current study is to assess the effects of eicosapentaenoic acid (EPA) supplementation on serum HSP-27, glycemic status and anthropometric indices in type 2 diabetes mellitus (T2DM) patients.<h4>Methods</h4>Thirty-six patients with T2DM were randomly allocated to obtain 2 g per day EPA (n = 18) or placebo (n = 18) for 8 weeks in a randomized, double-blind, ...[more]